DoubleTwist Licenses Prophecy Database to GPC Biotech | GenomeWeb

NEW YORK, Oct. 16 – DoubleTwist has licensed its Prophecy database and tools suite to GPC Biotech, the company said on Tuesday.

Financial terms of the agreement were not disclosed.

"DoubleTwist's Prophecy suite gives us comprehensive access to annotated public genome data and effective tools for their use,” Greg Hamm, vice president for bioinformatics at GPC Biotech said in a statement. “We are looking forward to mining this valuable data set.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.